HomeCompareMIXT vs MRK

MIXT vs MRK: Dividend Comparison 2026

MIXT yields 1.65% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MIXT wins by $28.66M in total portfolio value· pulled ahead in Year 3
10 years
MIXT
MIXT
● Live price
1.65%
Share price
$14.55
Annual div
$0.24
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.72M
Annual income
$25,722,713.87
Full MIXT calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MIXT vs MRK

📍 MIXT pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMIXTMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MIXT + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MIXT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MIXT
Annual income on $10K today (after 15% tax)
$140.21/yr
After 10yr DRIP, annual income (after tax)
$21,864,306.79/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MIXT beats the other by $21,855,978.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MIXT + MRK for your $10,000?

MIXT: 50%MRK: 50%
100% MRK50/50100% MIXT
Portfolio after 10yr
$14.39M
Annual income
$12,866,256.00/yr
Blended yield
89.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MIXT
Analyst Ratings
3
Buy
1
Hold
Consensus: Buy
Price Target
$12.00
-17.5% upside vs current
Range: $12.00 — $12.00
Altman Z
4.4
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MIXT buys
0
MRK buys
0
No recent congressional trades found for MIXT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMIXTMRK
Forward yield1.65%2.76%
Annual dividend / share$0.24$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$28.72M$56.8K
Annual income after 10y$25,722,713.87$9,798.13
Total dividends collected$28.46M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$12.00$128.54

Year-by-year: MIXT vs MRK ($10,000, DRIP)

YearMIXT PortfolioMIXT Income/yrMRK PortfolioMRK Income/yrGap
1$11,030$329.90$11,206$366.19$176.00MRK
2$12,482$680.14$12,650$502.35$168.00MRK
3← crossover$14,795$1,438.66$14,407$694.19+$388.00MIXT
4$19,017$3,187.27$16,585$967.82+$2.4KMIXT
5$28,007$7,657.99$19,342$1,363.89+$8.7KMIXT
6$51,047$21,079.98$22,913$1,947.19+$28.1KMIXT
7$126,437$71,816.86$27,662$2,823.89+$98.8KMIXT
8$467,776$332,488.59$34,159$4,173.35+$433.6KMIXT
9$2,799,771$2,299,250.67$43,337$6,308.80+$2.76MMIXT
10$28,718,469$25,722,713.87$56,776$9,798.13+$28.66MMIXT

MIXT vs MRK: Complete Analysis 2026

MIXTStock

MiX Telematics Limited provides fleet and mobile asset management solutions through software-as-a-service (Saas) delivery model. The company offers MiX Fleet Manager, a web-based application, which provides commercial fleet management solution that gives user live and historical views of driver and vehicle performance information, including vehicle tracking and status information, as well as alerts and notifications; MiX Asset Manager, a portfolio of asset tracking products comprising generators, light towers, storage tanks, and pumps; and Matrix, a mobile asset management solutions that offers real-time and historical vehicle tracking and positioning, unauthorized vehicle use alerts, panic emergency response, crash alerts, driver behavior alerts, fuel tax logbooks, and vehicle maintenance notifications for entry-level fleets and consumers. It also provides Beam-e, a crowdsourcing platform to locate vehicles without the expense of utilizing a traditional cellular network connection, and entry-level tracking and recovery services; MiX Now, a system that helps companies monitor and manage the behavior and performance of their vehicles and drivers. It delivers fleet and mobile asset management solutions as SaaS to 815,165 subscribers in South Africa, the Americas, the Middle East, Australia, Europe, and Brazil. MiX Telematics Limited was founded in 1996 and is headquartered in Boca Raton, Florida.

Full MIXT Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MIXT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MIXT vs SCHDMIXT vs JEPIMIXT vs OMIXT vs KOMIXT vs MAINMIXT vs JNJMIXT vs ABBVMIXT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.